Sunday, October 29, 2006
Where's the justice?
Exactly how much is being pilfered from both shareholders and taxpayers by "white collar criminals"? Enron and Worldcom got the press's attention, but most don't. The point here is these cases are typically history by the time they are prosecuted, hence the "loot is long gone". Messrs. Hal S. Scott (Harvard Law) and R. Glenn Hubbard (former member of Council of Economic Advisors), among others want to provide greater protections for white collar criminals in the name of "cost-effective regulation". The argument that our capital markets are losing business because of liability issues relating to enforcement of the Sarbanes-Oxley Act is surely a red-herring indeed. Our capital markets work solely because of the confidence of its investors. The public's confidence in our capital markets is severely undermined by the presence of white collar criminals in corporate America. Shielding these "vermin" under any guise is morally unacceptable and intellectually disingenuous. Corporate coffers demand better oversight, not less.
Exactly how much is being pilfered from both shareholders and taxpayers by "white collar criminals"? Enron and Worldcom got the press's attention, but most don't. The point here is these cases are typically history by the time they are prosecuted, hence the "loot is long gone". Messrs. Hal S. Scott (Harvard Law) and R. Glenn Hubbard (former member of Council of Economic Advisors), among others want to provide greater protections for white collar criminals in the name of "cost-effective regulation". The argument that our capital markets are losing business because of liability issues relating to enforcement of the Sarbanes-Oxley Act is surely a red-herring indeed. Our capital markets work solely because of the confidence of its investors. The public's confidence in our capital markets is severely undermined by the presence of white collar criminals in corporate America. Shielding these "vermin" under any guise is morally unacceptable and intellectually disingenuous. Corporate coffers demand better oversight, not less.
Labels: Sarbanes-Oxley
Thursday, October 05, 2006
Where's the "Mystery of aging"?
The New York Times is devoting space to a 3 part piece on the "Mystery of Aging". Contemporary society too often is looking for the "quick fix", "free lunch" or the "easy way out". Rest assured, none of the above applies to our body. We need no studies to understand the significant role atrophy plays in our well-being. It's this simple... Use it or lose it. Drugs and modern medicine, our quick fixes, are no substitute for activity and human interaction, both of which contribute to the amelioration of atrophy. There is simply no substitutes for either.
The medical community will use the term "frailty" to describe human atrophied condition. The implication of this terminology is that atrophy is just another disorder that is treatable with medical procedures and drugs. Atrophy is a personal challenge to our own longevity and well-being. It really is this simple...Use it or lose it, life that is.
The New York Times is devoting space to a 3 part piece on the "Mystery of Aging". Contemporary society too often is looking for the "quick fix", "free lunch" or the "easy way out". Rest assured, none of the above applies to our body. We need no studies to understand the significant role atrophy plays in our well-being. It's this simple... Use it or lose it. Drugs and modern medicine, our quick fixes, are no substitute for activity and human interaction, both of which contribute to the amelioration of atrophy. There is simply no substitutes for either.
The medical community will use the term "frailty" to describe human atrophied condition. The implication of this terminology is that atrophy is just another disorder that is treatable with medical procedures and drugs. Atrophy is a personal challenge to our own longevity and well-being. It really is this simple...Use it or lose it, life that is.
Labels: Aging
